Saturday, June 13, 2026
FB X LI YT
Breaking
ABIOLA AND THE ANCIENT JOURNEY OF JUNE 12 – By Dare Babarinsa, CON Otunba Bimbo Ashiru, Group Chairman of Oodua Investment Company Limited, speaks at the Think Yoruba First 4th Global Conference. A proud moment for Yoruba land as he addresses the gathering on regional unity and progress. Representative from the DAWN Commission speaks at the Think Yoruba First 4th Global Conference, addressing the gathering on regional integration, collaboration with Think Yoruba First, and the future of Yoruba land in a multipolar world. The event was held in partnership with the DAWN Commission. Otunba Deji Osibogun, Convener of Yoruba Koya Leadership and Training Foundation, speaks at the Think Yoruba First 4th Global Conference. He addressed the gathering on leadership development, grassroots mobilisation, and the urgent need to build the next generation of Yoruba leaders. Oba Francis Olusola Alao, the Olugbon of Orile-Igbon Kingdom, speaks at the Think Yoruba First 4th Global Conference. The royal father spoke on the critical role of traditional institutions in securing the nation and praised Think Yoruba First for their tireless work in advancing the cause of Yoruba land, declaring that the movement is the future of Yoruba progress and unity. “No One Is More Qualified Than Me” – Senator Dickson Declares Obi Not Doing NDC Any Favour Caribbean Nation Opens Doors: Grenada Grants Nigerians Visa-Free Access, Seeks Direct Flights and Investment Economic Invasion, Physical and Psychological Warfare on Yoruba Land
NEWS

Africa Begins Rollout of Groundbreaking HIV-Prevention Injection

December 1, 2025 • 2 min read

December 1, 2025
By Ayinde Adeleke

African health authorities have begun administering Lenacapavir, a groundbreaking HIV-prevention injection that has shown remarkable success in reducing the risk of HIV transmission by more than 99.9 percent. The long-acting drug, taken just twice a year, is being described by medical experts as one of the most significant advancements in HIV prevention to date, with its effectiveness making it “functionally comparable to a powerful vaccine.”

The rollout officially commenced today in South Africa, Eswatini, and Zambia, three countries with some of the highest HIV prevalence rates globally. Public health officials say the introduction of Lenacapavir represents a major step forward in the continent’s ongoing efforts to curb new infections and expand access to reliable preventive care.

Developed as a biannual injection, Lenacapavir works by blocking the virus from replicating in the body, offering long-term protection for individuals at high risk of exposure. Its extended dosing schedule is expected to improve adherence, particularly among vulnerable groups who may struggle with daily or monthly medication routines.

Regional health ministries have expressed optimism that the new injection will significantly reduce transmission rates, ease the burden on healthcare systems, and accelerate progress towards achieving global HIV-reduction targets. International health partners and donor agencies have also pledged support to ensure equitable access as more African countries prepare to join the rollout.

The introduction of Lenacapavir has been widely praised by public health advocates as a transformative milestone for HIV prevention in Africa, with experts calling it a critical tool in the continent’s fight to end new infections in the coming decades.